BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 2, 2017
View Archived Issues
Opiant receives FDA feedback on development of OPNT-002 for alcohol use disorder
Read More
Novel fixed dose combination EHCV shows promise against chronic hepatitis C in clinical study
Read More
Amgen reports overall survival data from ENDEAVOUR study of Kyprolis
Read More
GS-PI-1 is a promising new generation HIV PI with favorable potency and resistance barrier
Read More
Promising results from the BCN02-Romi study of MVA.HIVconsv vaccine
Read More
Invenra and QIMR Berghofer collaborate to discover therapeutic antibodies
Read More
Bristol-Myers Squibb announces investment and plans for collaboration with Grail
Read More
EMA grants PRIME access to givosiran for acute hepatic porphyrias
Read More
European Commission approves Vihuma
Read More
European Commission grants orphan drug designation to apatinib for gastric cancer
Read More
Audentes initiates LUSTRO study in Crigler-Najjar syndrome
Read More
Pivotal Phase III study results for Merck & Co.'s varicella zoster virus vaccine presented
Read More
Arrakis Therapeutics completes Series A financing
Read More
SB-913 from Sangamo Therapeutics granted U.S. orphan drug designation for the treatment of MPS II
Read More
Boehringer Ingelheim's BI-836858 given U.S. orphan drug designation for the treatment of MDS
Read More
Sellas reports updated phase II data on galinpepimut-S in multiple myeloma
Read More
European Commission grants orphan drug designation to ZX-008 for Lennox-Gastaut syndrome
Read More
FDA grants priority review to enasidenib NDA
Read More
Pfizer and iTeos Therapeutics identify tryptophan 2,3-dioxygenase inhibitors
Read More
Eli Lilly completes acquisition of CoLucid Pharmaceuticals
Read More
Hetero Research Foundation discloses novel antiviral agents
Read More
FDA allows PR-022 to proceed to phase II study for the treatment of atopic dermatitis
Read More
Myovant initiates phase III trial of relugolix for advanced prostate cancer
Read More
Toray Industries initiates first-in-human study of TRK-950 in advanced solid tumors
Read More
Intensity Therapeutics studies intratumorally dosed INT-230-6 in advanced cancers
Read More